| |
| |
| |
| Antipsychotics | |
| |
| |
| Second-Generation Antipsychotics | |
| |
| |
| First-Generation Antipsychotics | |
| |
| |
| References | |
| |
| |
| |
| Antidepressants | |
| |
| |
| Selective Serotonin Reuptake Inhibitors | |
| |
| |
| Third-Generation Antidepressants | |
| |
| |
| Tricyclic Antidepressants | |
| |
| |
| Monoamine Oxidase Inhibitors | |
| |
| |
| Benzodiazepines | |
| |
| |
| CNS Stimulants | |
| |
| |
| References | |
| |
| |
| |
| Mood Stabilizers | |
| |
| |
| Lithium | |
| |
| |
| Valproate | |
| |
| |
| Carbamazepine | |
| |
| |
| Lamotrigine | |
| |
| |
| Miscellaneous Treatments | |
| |
| |
| Benzodiazepines | |
| |
| |
| Clonidine | |
| |
| |
| Gabapentin | |
| |
| |
| Omega-3 Fatty Acids | |
| |
| |
| Oxcarbazepine | |
| |
| |
| Topiramate | |
| |
| |
| Verapamil | |
| |
| |
| References | |
| |
| |
| |
| Antianxiety Agents (Anxiolytics) | |
| |
| |
| Benzodiazepines | |
| |
| |
| Antidepressants | |
| |
| |
| [beta]-Adrenergic Blocking Drugs | |
| |
| |
| Buspirone | |
| |
| |
| Miscellaneous Agents | |
| |
| |
| References | |
| |
| |
| |
| Hypnotics | |
| |
| |
| Definition and Evaluation of Insomnia | |
| |
| |
| Nonpharmacologic Treatment of Insomnia | |
| |
| |
| Pharmacologic Treatment of Insomnia | |
| |
| |
| Benzodiazepine Receptor Agonists | |
| |
| |
| Non-Benzodiazepine Receptor Agonists | |
| |
| |
| Rational Prescribing of Hypnotics for Insomnia | |
| |
| |
| Dietary Supplements for Treatment of Insomnia | |
| |
| |
| Valerian | |
| |
| |
| Melatonin | |
| |
| |
| Tryptophan | |
| |
| |
| Rational Prescribing of Dietary Supplements for Insomnia | |
| |
| |
| Narcotherapy | |
| |
| |
| References | |
| |
| |
| |
| Psychotropic Drug Treatment of Alcohol and Drug Dependence | |
| |
| |
| Disulfiram | |
| |
| |
| Naltrexone | |
| |
| |
| Acamprosate | |
| |
| |
| Methadone and L-[alpha]-Acetyl Methadol | |
| |
| |
| Buprenorphine | |
| |
| |
| Promising Drugs for Treatment of Substance Dependence | |
| |
| |
| References | |
| |
| |
| |
| Drug Interactions | |
| |
| |
| Types of Drug Interactions | |
| |
| |
| Opportunities for Drug Interactions | |
| |
| |
| Evidence for Drug Interactions | |
| |
| |
| Explanations for Minimal Expression of Adverse Drug Interactions | |
| |
| |
| References | |
| |
| |
| |
| Management of Acute Drug Withdrawal | |
| |
| |
| Ethanol Withdrawal | |
| |
| |
| Anxiolytic-Hypnotic Withdrawal | |
| |
| |
| Opiate Withdrawal | |
| |
| |
| Nicotine Withdrawal | |
| |
| |
| Central Nervous System Stimulant Withdrawal | |
| |
| |
| References | |
| |
| |
| |
| Electroconvulsive Therapy | |
| |
| |
| Indications | |
| |
| |
| Efficacy | |
| |
| |
| Mechanism of Action | |
| |
| |
| Treatment-Related Variables | |
| |
| |
| Adverse Effects | |
| |
| |
| Devices Used in ECT | |
| |
| |
| Method of Administration | |
| |
| |
| Medications Used in ECT | |
| |
| |
| Rational Prescribing | |
| |
| |
| References | |
| |
| |
| |
| Pharmacotherapy of Childhood and Adolescent Psychiatric Disorders | |
| |
| |
| Psychostimulants | |
| |
| |
| Antidepressants | |
| |
| |
| Antipsychotics | |
| |
| |
| Mood Stabilizers | |
| |
| |
| [alpha subscript 2]-Adrenergic Agonists | |
| |
| |
| Anxiolytics | |
| |
| |
| References | |
| |
| |
| |
| Geriatrics | |
| |
| |
| Introduction | |
| |
| |
| Challenges and Guidelines of Psychotropic Drug Prescribing to the Geropsychiatric Patient | |
| |
| |
| Pharmacokinetic and Dynamic Changes Occurring with Normal Aging | |
| |
| |
| Mental Disorders and Other Treatable Conditions in the Elderly | |
| |
| |
| Dementia | |
| |
| |
| Overview of Drugs Used for the Treatment of Dementia | |
| |
| |
| Acetylcholinesterase Inhibitors | |
| |
| |
| NMDA Antagonist: Memantine | |
| |
| |
| Depression | |
| |
| |
| Nonpharmacologic Treatment | |
| |
| |
| Pharmacotherapy of Depression in AD | |
| |
| |
| Pharmacotherapy of Late-Life Depression | |
| |
| |
| Pharmacotherapy of Depression with Medical Illness | |
| |
| |
| Anxiety, Agitation, and Behavioral Problems | |
| |
| |
| Sleep Problems | |
| |
| |
| Summary | |
| |
| |
| References | |
| |
| |
| |
| Psychotropic Drug Product List | |
| |
| |
| |
| Pregnancy Risk and Lactation Categories | |
| |
| |
| |
| Psychotropic Drug Pharmacokinetic Parameters | |
| |
| |
| |
| Psychotropic Drug Interactions | |
| |
| |
| Index | |